Skip to main content
. Author manuscript; available in PMC: 2009 Jun 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2008 Jun;6(6):661–670. doi: 10.1016/j.cgh.2008.02.033

Table 2.

Cost-Minimization Analysis with Therapy or Definitive Diagnosis as Model Endpoint

Rank Strategy Value, $ Incremental Cost, $
1 DBE 3,824 0
2 CE 4,263 440
3 SBFT 4,311 488
4 EN 4,331 508
5 PE 4,408 585